BIOAMBER INC. (NYSE:BIOA) Files An 8-K Other Events
Item 8.01 Other Events
On April 27, 2017, BioAmber Inc. filed with the British Columbia
Securities Commission a prospectus in connection with its
application to list its common stock on the Toronto Stock
Exchange.Such prospectus contained, among other things,
descriptions of our business and operations, a copy of which is
attached hereto as Exhibit 99.1.On May 1, 2017, BioAmber Inc.
issued a press release captioned BioAmber Announces Trading on
Toronto Stock Exchange Market Commencing on May 3, 2017, a copy
of which is attached hereto as Exhibit 99.2 to this Current
Report on Form 8-K and is incorporated herein by reference.
Item 9.01Financial Statements and Exhibits
Final prospectus dated April 27, 2017
Press release of BioAmber Inc. issued on May 1, 2017
About BIOAMBER INC. (NYSE:BIOA)
BioAmber Inc. (BioAmber), formerly DNP Green Technology, Inc., is an industrial biotechnology company, which produces sustainable chemicals. The Company’s technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstocks into sustainable chemicals that are replacements for petroleum-derived chemicals, which are used in a range of everyday products, including plastics, food additives and personal care products. Its geographical segments include Europe and North America. Its product pipeline includes the derivatives of bio-succinic acid, such as 1,4 Butanediol (1,4 BDO) and tetrahydrofuran (THF), and succinic acid-based polyesters, and C6 building block chemicals, such as adipic acid, caprolactam and hexamethylenediamine (HMDA). Its products are used in various applications, including polyurethanes, resins and coatings, de-icing and coolant solutions, fine chemicals, lubricants, carpets, engineering plastics and artificial leather products. BIOAMBER INC. (NYSE:BIOA) Recent Trading Information
BIOAMBER INC. (NYSE:BIOA) closed its last trading session down -0.06 at 2.15 with 74,668 shares trading hands.